Sabril Patient Registry
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2016
At a glance
- Drugs Vigabatrin (Primary)
- Indications Complex partial epilepsy; Infantile spasms
- Focus Adverse reactions
- Sponsors Lundbeck A/S
- 28 Jul 2016 Status changed from recruiting to completed.
- 03 May 2014 Interim 4-year results presented at the 66th Annual Meeting of the American Academy of Neurology.
- 03 Dec 2012 Three-year vision data from were presented as a late-breaking poster at the Annual Meeting of the American Epilepsy Society (AES) in December 2012.